The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Jazz Pharmaceuticals plc shares valued at $548,250 were sold by Patil Neena M on May 03 ’24. At $109.65 per share, Patil Neena M sold 5,000 shares. The insider’s holdings dropped to 36,629 shares worth approximately $4.14 million following the completion of this transaction.
Also, Carr Patricia sold 1,768 shares, netting a total of over 206,821 in proceeds. Following the sale of shares at $116.98 each, the insider now holds 6,596 shares.
Before that, Carr Patricia had sold 1,936 shares from its account. In a trade valued at $231,628, the SVP, Chief Accounting Officer traded Jazz Pharmaceuticals plc shares for $119.64 each. Upon closing the transaction, the insider’s holdings decreased to 1,936 shares, worth approximately $0.95 million.
As published in their initiating research note from Robert W. Baird on January 03, 2024, Jazz Pharmaceuticals plc [JAZZ] has been an Outperform and the price target has been revised to $160. Analysts at UBS downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late November. As of September 29, 2023, Raymond James has initiated its “Mkt perform” rating for JAZZ.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 3.50%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -8.03%. Shares of the company reached a 52-week high of $134.17 on 02/26/24 and a 52-week low of $103.01 on 05/02/24. A 50-day SMA is recorded $115.03, while a 200-day SMA reached $124.68. Nevertheless, trading volume fell to 0.81 million shares from 0.84 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 110.89, which, if violated, would cause prices to drop to 108.65. In the upper region, resistance lies at 114.27. The next price resistance is at 115.41. RSI (Relative Strength Index) is 53.41 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.66, which suggests the price will increase in the coming days. Percent R is at 2.32%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
